at 08:05 Daiichi Sankyo to Showcase TURALIO® Research in Patients with Tenosynovial ... With the news, HealthTap is... Astria Therapeutics, Inc. , a biopharmaceutical company focused on developing ...
Viasat, Inc. , a global communications company, today announced the launch of its innovative home and mobile broadband service in Mexico. Viasat, in collaboration with Altán, the Mexican ...
LONDON — AstraZeneca said Tuesday it has had to resubmit a closely watched medicine for U.S. approval in a different form of ...
AstraZeneca (AZN) and Daiichi Sankyo have submitted a new Biologics License Application for accelerated approval in the US for datopotamab deruxtecan for the treatment of adult patients with locally ...
Alteogen Inc. said that it has entered into an exclusive license agreement with Daiichi Sankyo (DSKYF.PK). As per the terms of the ...
A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...
Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.
The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is anticipated to be dominated ...
New Delhi, The Delhi High Court on Tuesday ordered auctioning of the Fortis trademark in connection with the ₹3,500 crore arbitral award passed in favour of Japanese pharma major Daiichi Sankyo ...
"With the approval of Epinephrine Injection, USP we continue to show our commitment to ensuring both patients and providers ...
Speakers from Almirall, AstraZeneca, Bayer, BioNTech, Glenmark, and GSK share innovative approaches to drive commercial excellence BARCELONA, Spain, Oct. 29, 2024 /PRNewswire/ -- Veeva ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback